Lindbrook Capital, LLC - TURNING POINT THERAPEUTICS I ownership

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$6,000
-25.0%
80
-72.9%
0.00%0.0%
Q1 2022$8,000
-83.7%
295
-71.2%
0.00%
-85.7%
Q4 2021$49,000
+2350.0%
1,025
+4559.1%
0.01%
Q1 2021$2,0000.0%22
-31.2%
0.00%
-100.0%
Q4 2019$2,000320.00%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders